FN2 Earnings Intelligence
Labcorp Holdings Inc. ratios (quarterly)
Labcorp Holdings Inc. (LH) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $369.4 | $647.3 | $598.1 | $981.1 | $141.8 | - | - |
| + Debt | $5,569.1 | $5,077.7 | $5,082.9 | $5,834.1 | $5,858.5 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $3,345.1 | $3,527.3 | $3,563.5 | $3,537.6 | $3,731.1 | $3,755.6 | $3,716.6 |
| % Growth | - | - | - | - | - | 5.4% | - |
| Gross Profit | $948 | $1,046.2 | $1,025.1 | $1,013.8 | $1,112 | - | - |
| % Margin | 28.3% | 29.7% | 28.8% | 28.7% | 29.8% | - | - |
| EBITDA | $492.8 | $459.9 | $463 | $554.1 | $519.7 | - | - |
| % Margin | 14.7% | 13.0% | 13.0% | 15.7% | 13.9% | - | - |
| Net Income | $212.8 | $237.9 | $261.1 | $277.8 | $298.7 | - | - |
| % Margin | 6.4% | 6.7% | 7.3% | 7.9% | 8.0% | - | - |
| Diluted EPS | $2.52 | $2.84 | $3.12 | $3.35 | $3.64 | $4.65 | $4.45 |
| % Growth | - | - | - | - | - | 49.1% | - |
| Operating Cash Flow | $18.5 | - | - | $191.5 | - | - | - |
| CapEx | $126 | - | - | $121 | - | - | - |
| Free Cash Flow | -$107.5 | - | - | $70.5 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $3,345.1 | $3,527.3 | $3,563.5 | $3,537.6 | $3,731.1 | $3,755.6 | $3,716.6 |
| Gross Profit | $948 | $1,046.2 | $1,025.1 | $1,013.8 | $1,112 | - | - |
| EBITDA | $492.8 | $459.9 | $463 | $554.1 | $519.7 | - | - |
| Net Income | $212.8 | $237.9 | $261.1 | $277.8 | $298.7 | - | - |
| Diluted EPS | $2.52 | $2.84 | $3.12 | $3.35 | $3.64 | $4.65 | $4.45 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $369.4 | $647.3 | $598.1 | $981.1 | $141.8 |
| Short-term Debt | $0.4 | $0.4 | $0.4 | $0.4 | $0.9 |
| Long-term Debt | $5,568.7 | $5,077.3 | $5,082.5 | $5,833.7 | $5,857.6 |
| Total Debt | $5,569.1 | $5,077.7 | $5,082.9 | $5,834.1 | $5,858.5 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $18.5 | - | - | $191.5 | - |
| Capital Expenditure | $126 | - | - | $121 | - |
| Free Cash Flow | -$107.5 | - | - | $70.5 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 28.3% | 29.7% | 28.8% | 28.7% | 29.8% |
| EBITDA Margin | 14.7% | 13.0% | 13.0% | 15.7% | 13.9% |
| Net Margin | 6.4% | 6.7% | 7.3% | 7.9% | 8.0% |
| FCF Margin | -3.2% | - | - | 2.0% | - |
| Diluted EPS Growth | - | - | - | - | - |